07:06 AM EST, 12/09/2025 (MT Newswires) -- CVS Health ( CVS ) said Tuesday it has raised its 2025 adjusted EPS guidance to a range of $6.60 to $6.70, from $6.55 to $6.65.

Analysts polled by FactSet expect $6.62.

The company also raised its revenue guidance for the year ending Dec. 31, 2025 to at least $400.0 billion, up from at least $397.3 billion previously.

Analysts surveyed by FactSet expect $398.40 billion.

For 2026, the company expects adjusted EPS of $7.00 to $7.20 and revenue of at least $400.0 billion.

Analysts polled by FactSet expect $7.17 and $420.34 billion, respectively.